Inactive Instrument
Onconova Therapeutics Inc Share Price Nasdaq
Stocks
US68232V1089
Biotechnology & Medical Research
| Market Cap | 12.88M 11.23M 10.4M 9.74M 18.26M 1.22B 18.37M 123M 47.83M 598M 48.36M 47.32M 2.08B | P/E 2026 * |
-0.6x | P/E 2027 * | -0.67x |
|---|---|---|---|---|---|
| Enterprise Value | 12.88M 11.23M 10.4M 9.74M 18.26M 1.22B 18.37M 123M 47.83M 598M 48.36M 47.32M 2.08B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Onconova Therapeutics Inc
| 1 day | -5.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Dukes
CEO | Chief Executive Officer | 67 | 30/03/2025 |
Charles Parker
DFI | Director of Finance/CFO | 46 | 04/07/2025 |
Robert Redfield
CTO | Chief Tech/Sci/R&D Officer | 74 | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Stover
CHM | Chairman | 73 | 14/04/2025 |
Mary Shoemaker
BRD | Director/Board Member | 64 | 31/03/2020 |
Trafford Clarke
BRD | Director/Board Member | 67 | 18/12/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.13% | +0.55% | - | - | 12.88M | ||
| +1.44% | +1.71% | -10.98% | -5.59% | 43.13B | ||
| +3.31% | +5.93% | +310.97% | +532.23% | 34.65B | ||
| +2.84% | +2.14% | +9.34% | +45.55% | 30.03B | ||
| -1.70% | -7.54% | +8.43% | -21.54% | 28B | ||
| -1.90% | -1.56% | +10.24% | +22.81% | 24.45B | ||
| -0.14% | +5.86% | - | - | 14.34B | ||
| +0.68% | -1.53% | +48.76% | +108.76% | 13.14B | ||
| -0.57% | -2.43% | +5.08% | +6.76% | 12.53B | ||
| -0.26% | +1.15% | +98.13% | +79.60% | 12.25B | ||
| Average | -0.14% | +0.73% | +60.00% | +96.07% | 23.61B | |
| Weighted average by Cap. | +0.77% | +1.27% | +65.47% | +111.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -21.3M -18.57M -17.2M -16.1M -30.2M -2.01B -30.38M -204M -79.08M -989M -79.95M -78.24M -3.43B | -24.25M -21.14M -19.58M -18.33M -34.38M -2.29B -34.59M -232M -90.03M -1.13B -91.03M -89.08M -3.91B |
| Net Debt | - | - |
Employees
-

















